Pulse Biosciences, Inc. PLSE Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s accounts payable?
- Pulse Biosciences, Inc. (PLSE) reported accounts payable of $2.76M in Q1 2026.
- How has Pulse Biosciences, Inc.'s accounts payable changed year-over-year?
- Pulse Biosciences, Inc.'s accounts payable increased by 16.5% year-over-year, from $2.37M to $2.76M.
- What is the long-term trend for Pulse Biosciences, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s accounts payable has grown at a 10.1% compound annual growth rate (CAGR), from $1.72M to $2.78M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.